FDA Approval of Cabozantinib - CABINET in pNET & epNET

Key Points

• The history of treatment strategies for neuroendocrine tumors

• CABINET study design and outcomes insights

• Treatment option sequencing in patients with neuroendocrine tumors

• Side effects and management of cabozantinib

• The role of personalized treatment strategies in oncology